Faulkes Martin Charles
SEC CIK 1577872 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| VNRX | VOLITIONRX LTD | Executive Dir, Dir | 1.74M | $127.9K | — | 13 | 2022-04-07 | 2024-01-24 |
Most active insiders at VNRX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Reynolds Cameron John | Pres, CEO, Dir | $63.1K | — |
| 2 | Innes Guy Archibald | Dir | $49.0K | — |
| 3 | STILL TIMOTHY I | Dir | $24.5K | — |
| 4 | Rubin Ethel | Dir | — | — |
| 5 | Retter Andrew | Chief Medical Off | — | — |
| 6 | Batchelor Ann-Louise | Group CMO | — | — |
| 7 | Henshall Mickie | Dir | — | — |
| 8 | Plummer Nicholas | GC - Volition Diagnostics | — | — |
| 9 | Nguyen Kim | Dir | — | — |
| 10 | Forterre Gael | Chief Commercial Off | — | — |
Faulkes Martin Charles made no open-market trades at VNRX in the last 12 months.
Transactions 13
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-01-26 | 2024-01-24 | VNRX | VOLITIONRX LTD | Faulkes Martin Charles | Executive Dir, Dir | A - Grant | $0.00 | +22.5K | 1.74M | +1% | $0 | |
| 2023-10-20 | 2023-10-19 | VNRX | VOLITIONRX LTD | Faulkes Martin Charles | Executive Dir, Dir | A - Grant | $0.00 | +50.0K | 1.72M | +3% | $0 | |
| 2023-10-06 | 2023-10-04 | VNRX | VOLITIONRX LTD | Faulkes Martin Charles | Dir | F - Tax | $0.68 | -5,850 | 1.67M | -0.3% | -$3,978 | |
| 2023-09-01 | 2023-08-31 | VNRX | VOLITIONRX LTD | Faulkes Martin Charles | Dir | P - Purchase | $1.28 | +9,716 | 1.67M | +0.6% | +$12.4K | |
| 2023-08-07 | 2023-08-03 | VNRX | VOLITIONRX LTD | Faulkes Martin Charles | Dir | F - Tax | $1.30 | -5,427 | 1.66M | -0.3% | -$7,055 | |
| 2023-07-07 | 2023-07-05 | VNRX | VOLITIONRX LTD | Faulkes Martin Charles | Dir | A - Grant | $0.00 | +17.6K | 1.67M | +1% | $0 | |
| 2023-01-13 | 2023-01-12 | VNRX | VOLITIONRX LTD | Faulkes Martin Charles | Dir | A - Grant | $0.00 | +14.6K | 1.65M | +0.9% | $0 | |
| 2022-12-19 | 2022-12-16 | VNRX | VOLITIONRX LTD | Faulkes Martin Charles | Dir | P - Purchase | $2.10 | +55.0K | 1.64M | +3% | +$115.5K | |
| 2022-10-14 | 2022-10-13 | VNRX | VOLITIONRX LTD | Faulkes Martin Charles | Dir | A - Grant | $0.00 | +6,825 | 1.58M | +0.4% | $0 | |
| 2022-10-06 | 2022-10-04 | VNRX | VOLITIONRX LTD | Faulkes Martin Charles | Dir | A - Grant | $0.00 | +50.0K | 1.58M | +3% | $0 | |
| 2022-08-05 | 2022-08-03 | VNRX | VOLITIONRX LTD | Faulkes Martin Charles | Dir | F - Tax | $1.97 | -4,825 | 1.53M | -0.3% | -$9,505 | |
| D | 2022-06-24 | 2022-06-23 | VNRX | VOLITIONRX LTD | Faulkes Martin Charles | Dir | A - Grant | $0.00 | +15.7K | 1.53M | +1% | $0 |
| D | 2022-04-08 | 2022-04-07 | VNRX | VOLITIONRX LTD | Faulkes Martin Charles | Dir | A - Grant | $0.00 | +8,443 | 1.51M | +0.6% | $0 |
Purchase Sale Sale after option exercise All abbreviations